Key result
Study evaluates additional risk factors for LAA thrombosis in NVAF.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Additional LAA thrombosis factors in NVAF remain uncertain; hypothesis-generating and requires prospective validation before any clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khorkova et al. (2020) studied this question. Additional factors for left atrial appendage thrombosis in nonvalvular atrial fibrillation were evaluated, though specific results are not provided in the truncated abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: